Diabetes Collection
 21-40 of 110 Articles
ACP Journal Club |  15 October 2013
A lifestyle intervention did not reduce cardiovascular outcomes in overweight or obese patients with type 2 diabetes
Donald A. Smith, MD, MPH
Ann Intern Med. 2013;159(8):JC4. doi:10.7326/0003-4819-159-8-201310150-02004
ACP Journal Club |  17 September 2013
Insulin pumps with a sensor and threshold-suspend reduced nocturnal hypoglycemia in type 1 diabetes
Rozalina McCoy, MD; Steven Smith, MD
Ann Intern Med. 2013;159(6):JC7. doi:10.7326/0003-4819-159-6-201309170-02007
ACP Journal Club |  16 July 2013
Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease
Sanjum S. Sethi, MD; Michael E. Farkouh, MD, MSc
Ann Intern Med. 2013;159(2):JC3. doi:10.7326/0003-4819-159-2-201307160-02003
ACP Journal Club |  21 May 2013
An intensive lifestyle intervention increased remission from type 2 diabetes in overweight adults
Ma P. Kyithar, MD; Sean F. Dinneen, MD
Ann Intern Med. 2013;158(10):JC4. doi:10.7326/0003-4819-158-10-201305210-02004
ACP Journal Club |  16 April 2013
Metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD
Michael Tanner, MD, FACP
Ann Intern Med. 2013;158(8):JC4. doi:10.7326/0003-4819-158-8-201304160-02004
ACP Journal Club |  16 April 2013
Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes
Saurav Chatterjee, MD; Sanjay Chatterjee, MD
Ann Intern Med. 2013;158(8):JC8. doi:10.7326/0003-4819-158-8-201304160-02008
ACP Journal Club |  19 March 2013
Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs
Peter W. de Leeuw, MD
Ann Intern Med. 2013;158(6):JC7. doi:10.7326/0003-4819-158-6-201303190-02007
ACP Journal Club |  19 March 2013
PCI using drug-eluting stents had higher mortality than CABG in diabetes and multivessel CAD
Robert A. Harrington, MD
Ann Intern Med. 2013;158(6):JC8. doi:10.7326/0003-4819-158-6-201303190-02008
ACP Journal Club |  19 March 2013
Review: Continuous glucose monitoring reduces HbA1c more than self-monitoring in type 1 diabetes
A.C. Felix Burden, MD
Ann Intern Med. 2013;158(6):JC9. doi:10.7326/0003-4819-158-6-201303190-02009
ACP Journal Club |  15 January 2013
A single screening for type 2 diabetes in high-risk adults did not reduce mortality over 10 years
Jeffrey Mahon, MD, MSc
Ann Intern Med. 2013;158(2):JC4. doi:10.7326/0003-4819-158-2-201301150-02004
ACP Journal Club |  15 January 2013
Review: Intensive blood pressure control reduces stroke, but not mortality or MI, in type 2 diabetes
Louise Moist, MD
Ann Intern Med. 2013;158(2):JC5. doi:10.7326/0003-4819-158-2-201301150-02005
ACP Journal Club |  20 November 2012
Review: Intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes
Eugene C. Corbett Jr., MD, MACP
Ann Intern Med. 2012;157(10):JC5-6. doi:10.7326/0003-4819-157-10-201211200-02006
ACP Journal Club |  16 October 2012
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes
Juan P. Brito, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2012;157(8):JC4-7. doi:10.7326/0003-4819-157-8-201210160-02007
ACP Journal Club |  16 October 2012
Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes
Sean F. Dinneen, MD; Máire O’Donnell, PhD
Ann Intern Med. 2012;157(8):JC4-11. doi:10.7326/0003-4819-157-8-201210160-02011
ACP Journal Club |  18 September 2012
Glargine did not reduce CV events more than standard care in patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-10. doi:10.7326/0003-4819-157-6-201209180-02010
ACP Journal Club |  18 September 2012
Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-11. doi:10.7326/0003-4819-157-6-201209180-02011
ACP Journal Club |  21 February 2012
The optimal HbA1c cutpoint to screen for diabetes in the emergency department was 6.0%
Eddy S. Lang, MD
Ann Intern Med. 2012;156(4):JC2-11. doi:10.7326/0003-4819-156-4-201202210-02011
ACP Journal Club |  17 January 2012
Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes
Gabriela Prutsky, MD; Juan Pablo Domecq, MD; Apostolos Tsapas, MD, PhD
Ann Intern Med. 2012;156(2):JC1-7. doi:10.7326/0003-4819-156-2-201201170-02007
ACP Journal Club |  20 December 2011
Review: Intensive glucose lowering does not reduce mortality in type 2 diabetes
Vijaykumar Lingegowda, MD, MSEd, FASN
Ann Intern Med. 2011;155(12):JC6-4. doi:10.7326/0003-4819-155-12-201112200-02004
ACP Journal Club |  20 December 2011
Review: Insulin to maintain normoglycemia within 24 hours of ischemic stroke does not reduce death or dependency
Paul G. Wasielewski, MD; Ken Uchino, MD
Ann Intern Med. 2011;155(12):JC6-5. doi:10.7326/0003-4819-155-12-201112200-02005
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.